Literature DB >> 4037890

Seatone in rheumatoid arthritis.

R G Gibson, S L Gibson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4037890      PMCID: PMC1001730          DOI: 10.1136/ard.44.9.645-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Clinicians' expectations influence placebo analgesia.

Authors:  R H Gracely; R Dubner; W R Deeter; P J Wolskee
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

2.  Perna canaliculus in the treatment of rheumatoid arthritis.

Authors:  D E Caughey; R R Grigor; E B Caughey; P Young; P J Gow; A W Stewart
Journal:  Eur J Rheumatol Inflamm       Date:  1983

3.  Perna canaliculus in the treatment of arthritis.

Authors:  R G Gibson; S L Gibson; V Conway; D Chappell
Journal:  Practitioner       Date:  1980-09

4.  Prognostic value of early features in rheumatoid disease.

Authors:  A Fleming; J M Crown; M Corbett
Journal:  Br Med J       Date:  1976-05-22

5.  In vivo evidence for prostaglandin inhibitory activity in New Zealand green-lipped mussel extract.

Authors:  T Miller; H Wu
Journal:  N Z Med J       Date:  1984-06-13

6.  The anti-inflammatory activity of Perna canaliculus (NZ green lipped mussel).

Authors:  T E Miller; D Ormrod
Journal:  N Z Med J       Date:  1980-09-10

7.  Seatone in rheumatoid arthritis: a six-month placebo-controlled study.

Authors:  J G Larkin; H A Capell; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

  7 in total
  1 in total

Review 1.  Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus.

Authors:  Christopher S Cobb; Edzard Ernst
Journal:  Clin Rheumatol       Date:  2005-10-12       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.